Standout Papers
- Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases (1998)
- Nonmyeloablative Stem Cell Transplantation and Cell Therapy as an Alternative to Conventional Bone Marrow Transplantation With Lethal Cytoreduction for the Treatment of Malignant and Nonmalignant Hematologic Diseases (1998)
- Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma (2009)
Immediate Impact
4 by Nobel laureates 23 from Science/Nature 55 standout
Citing Papers
In vivo hematopoietic stem cell modification by mRNA delivery
2023 StandoutScienceNobel
Epigenetic Therapies for Cancer
2020 Standout
Works of Mark Kirschbaum being referenced
Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma
2011
Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma
2009 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Mark Kirschbaum | 1848 | 3156 | 1127 | 2056 | 66 | 6.1k | |
| Frederic I. Preffer | 1966 | 1550 | 892 | 2001 | 112 | 6.9k | |
| Stanley R. Frankel | 5085 | 2929 | 1184 | 1740 | 72 | 7.9k | |
| Joseph O. Moore | 1730 | 3266 | 977 | 1864 | 145 | 6.5k | |
| Anthony S. Stein | 1441 | 3809 | 867 | 2797 | 237 | 6.6k | |
| Dominique Bordessoule | 1324 | 2240 | 2291 | 2159 | 186 | 6.2k | |
| Yang O. Huh | 652 | 2407 | 1244 | 1144 | 103 | 4.6k | |
| Maurice Barcos | 1633 | 1755 | 1872 | 2854 | 136 | 6.4k | |
| Corrado Tarella | 1018 | 2452 | 2733 | 2780 | 205 | 6.1k | |
| Martin Gramatzki | 2054 | 1760 | 1136 | 2489 | 205 | 6.7k | |
| Gary Spitzer | 1325 | 3258 | 1577 | 2938 | 216 | 7.2k |
All Works
Loading papers...